Print Page  Close Window

SEC Filings

10-K
MYOKARDIA INC filed this Form 10-K on 03/08/2018
Entire Document
 

 

STOCK PERFORMANCE GRAPH

The following graph illustrates a comparison of the total cumulative stockholder return on our common stock since October 29, 2015, which is the date our common stock first began trading on the NASDAQ Global Select Market, to two indices: the NASDAQ Composite Index and the NASDAQ Biotechnology Index. The stockholder return shown in the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns. This graph shall not be deemed “soliciting material” or be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

 

 

Assumed $100 investment in stock or index

 

Ticker

 

October 29,

2015

 

 

December 31,

2015

 

 

December 31,

2016

 

 

December 31,

2017

 

MyoKardia, Inc. (MYOK)

 

MYOK

 

$

100

 

 

$

132

 

 

$

117

 

 

$

380

 

NASDAQ Composite (^IXIC)

 

IXIC

 

$

100

 

 

$

99

 

 

$

106

 

 

$

136

 

NASDAQ Biotechnology (^NBI)

 

NBI

 

$

100

 

 

$

102

 

 

$

80

 

 

$

97

 

 

DIVIDEND POLICY

We have never declared or paid any cash dividends on our capital stock. We currently expect to retain all future earnings, if any, for use in the operation and expansion of our business, and therefore do not anticipate paying any cash dividends in the foreseeable future.  

Securities Authorized for Issuance under Equity Compensation Plans

Information about our equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report on Form 10-K.

RECENT SALES OF UNREGISTERED SECURITIES

None.

61